Operating Expenses: The sum of all operating expenses for the given industry.
IN8bio, Inc. (INAB) had Operating Expenses of $3.97M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.85M |
|
-- |
|
-- |
|
|
Operating Expenses |
$3.97M |
$-3.97M |
|
$0.11M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.85M |
|
$-3.97M |
|
$-3.44M |
|
4.54M |
|
4.54M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$11.77M |
|
$2.10M |
|
$5.00M |
|
$16.77M |
|
$1.70M |
|
$0.06M |
|
$1.88M |
|
$3.58M |
|
$13.19M |
|
$13.19M |
|
$13.19M |
|
4.59M |
|
| Cash Flow Statement Financials | |
$-10.57M |
|
-- |
|
$10.15M |
|
$11.39M |
|
$10.96M |
|
$-0.42M |
|
$2.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.91 |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.22% |
|
-29.22% |
|
-22.98% |
|
-29.08% |
|
$2.87 |
|
$-2.33 |
|
$-2.33 |
|